About us
About OncoInv
OncoInv is a social enterprise and currently an entity of the Inspire2Live Foundation. Our goal is to diagnose cancer as early as possible, because early diagnosis leads to better treatment options and improved survival rates.
OncoInv’s mission is to make multi-cancer detection available to as many people as possible. The cancer burden is disproportionately high in Low- and Middle-Income Countries (LMICs), where most cancers are currently diagnosed at a late stage and treatment options are often very limited or unavailable. Late diagnosis is frequently caused by financial, logistical, and social barriers to accessing health care. With OncoSeek®, our multi-cancer detection product, these barriers can be minimised or even removed.
Additional use cases for multi-cancer detection include monitoring individuals with a high cancer risk profile, whether hereditary or contextual, testing symptomatic individuals, and use as a triage tool for waiting lists.
How we work
We work by collaborating closely with local partners in their own countries. Our starting point is always the same question: what is the most effective way to make multi-cancer detection available to the people who need it most?
Multi-cancer detection can be used for screening or annual check-ups, as well as for symptomatic individuals. Laboratory analyses can be performed in Europe. Distributors are also free to work with local laboratories to perform the test, which may reduce costs. Regardless of where testing takes place, it is essential that appropriate follow-up is arranged for individuals with a positive result. We require our distributors to organise or ensure follow-up by a health care professional, including clear guidance for patients.
We apply a differential pricing model based on the World Bank classification of high-income, upper-middle-income, lower-middle-income, and low-income countries. As a result, our activities in low- and middle-income countries are not-for-profit. This approach helps address inequalities in health care and enables us to reach as many people as possible.
Our Partners & Distributors
Our partners and distributors play a key role in making multi-cancer detection available in diverse local contexts. By working with organisations that understand regional health care systems and patient needs, we ensure responsible implementation and appropriate follow-up.
SeekIn
SeekIn develops innovative blood-based solutions for the early detection of cancer, enabling timely intervention and improved patient outcomes. By combining advanced analytics with accessible testing, the company aims to make early diagnosis a practical reality across diverse healthcare systems.
Visit SeekInLab Stein is a state-of-the-art clinical laboratory where blood samples are processed using advanced analytical technologies. The laboratory is committed to high detection accuracy, efficient workflows and reliable results, supporting healthcare providers with dependable laboratory services across multiple medical disciplines.
Visit Lab Stein
Excellion
Excellion is a healthcare company focused on promotive health services for vulnerable populations. It provides products and solutions that enhance early detection, diagnostics and disease prevention, helping improve access to essential health technologies in underserved communities.
Visit Excellion
Healthcare Systems Mexico
Healthcare Systems Mexico supports the hospital sector with integrated solutions for planning, equipping and connecting medical facilities. The organisation offers trusted global brands and provides services ranging from financing and construction to monitoring, diagnostics and hospital-wide software integration.
Visit Healthcare Systems Mexico
NM Genomix
NM Genomix is a leading genetic testing provider in Bulgaria, committed to a patient-centric approach in personalised medicine. The company delivers advanced diagnostic services designed to support early detection and informed clinical decision-making for individuals and healthcare professionals.
Visit NM Genomix
OnkoDiag
OnkoDiag collaborates with leading laboratories across Poland to provide patients with access to modern, high-quality laboratory diagnostics. The company is dedicated to reliable testing, professional standards and increasing the availability of advanced medical technologies nationwide.
Visit OnkoDiag
BIOS
BIOS is one of Pakistan’s leading healthcare solution providers, offering innovative diagnostic, therapeutic and treatment technologies. With a strong focus on patient-centred care, the organisation delivers advanced medical solutions designed to support personalised medicine and improve health outcomes across the region.
Visit BIOS
MaxBloch Laboratorios Clínicos
MaxBloch Clinical Laboratories is a leading diagnostic provider in El Salvador, with over 80 years of experience in laboratory medicine. The organisation offers high-quality diagnostic services across multiple locations, committed to accessible, ethical and reliable healthcare supported by internationally recognised quality standards.
Visit MaxBloch Laboratorios Clínicos
Universidad de Costa Rica
The Universidad de Costa Rica (UCR) is a leading public university in Latin America. Through its Centre for Research in Surgery and Cancer (CICICA-UCR), UCR conducts interdisciplinary research in cancer biology, early detection, and clinical translation within a public academic framework.
Visit Universidad de Costa RicaMedical Advisory Board
We work with a Medical Advisory Board of leading scientists and clinicians who provide current knowledge, critical thinking, and analysis to support informed decision-making.
The Inspire2Live Foundation holds a majority position on the board to ensure that OncoInv remains aligned with its mission as a social enterprise. Profits are reinvested in business growth and research and development, or used by Inspire2Live to support additional social projects.
Current members of the Medical Advisory Board include Professor Ifeoma Okoye MBBS, FWACS, FMCR and Stephen Friend from 4YouandMe.
Professor Stephen Friend
Professor Ifeoma Okoye